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Background: Quality of life (QoL) is a crucial outcome measure in patients with lower limb ischemia (LLI). The Short
Form 36 (SF36) has been proposed as the gold standard instrument for generic QoL analysis in patients with LLI. The
Short Form 8 (SF8) was developed from the SF36 and we aim to compare these two instruments in terms of validity,
reliability, and responsiveness.
Methods: One hundred ninety-three patients, 135 men and 58 women, median age 66 (range, 44-84) years with LLI
completed the SF36 and the SF8. Disease severity was graded according to International Society of Cardiovascular
Surgery (ISCVS) suggested reporting standards. Correlation between the two instruments’ like domains and non-like
domains reflects convergent and divergent validity respectively. A subgroup of 58 patients (44 men) completed two sets
of questionnaires, with an intervening period of 2 weeks. Correlation between these two sets of questionnaires was used
to analyze test/retest reliability. Spearman’s rank correlation was used to analyze validity and reliability. Responsiveness
of the individual domains across the whole group was analyzed using the Kruskall-Wallis analysis of variance (ANOVA)
test, while responsiveness between the groups of patients with varying severity of LLI was analyzed using the
Mann-Whitney U test.
Results: There was greater correlation between like domains of SF36 and the SF8 than the non-like domains suggesting
good convergent–divergent validity. Test/retest reliability was significant for both instruments (rs> 0.7). Increasing LLI
resulted in a statistically significant deterioration in all eight domains of both instruments. The time taken was
significantly shorter and less assistance was required to complete the SF8 than the SF36.
Conclusion: The SF8 is a valid and reliable QoL instrument in patients with LLI, and as it is simpler and quicker to
complete, we suggest it may challenge the SF36 as the gold standard generic QoL analysis instrument in LLI. (J Vasc
Surg 2009;49:122-6.)Quality of life (QoL) analysis is an essential outcome
measure in chronic disease.1 During the last decade, nu-
merous studies have investigated the role of QoL analysis in
lower limb ischemia (LLI) and it is now recognized as the
most important primary endpoint in evaluating the effect of
treatment in patients with LLI.2-9 Quality of life may be
analyzed using either generic or disease-specific instru-
ments.10,11 Generic instruments typically analyze global
QoL domains including physical, social, and psychological
well being. The main advantage of generic QoL instru-
ments is their “off the shelf” availability, allowing compar-
ison between differing disease states and populations. The
medical outcome study (MOS) 36-item short form (SF36)
health survey is the most widely used generic QoL tool and
it has been rigorously tested for validity, reliability, and
responsiveness.12-15 Ten years ago, the SF36 was recom-
mended as the gold standard European generic QoL in-
strument against which other instruments may be
gauged.16 However, the SF36 is lengthy, time consuming
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122to complete and score, and associated with a significant
incidence of incomplete responses. These problems repre-
sent practical obstacles to its routine use in clinical practice.
In an attempt to address these problems, a new instrument,
the short form 8 (SF8) has been developed from the SF36,
with a reduction in items from 36 to 8.12 We aimed to
assess whether the SF8 was as valid, reliable, and responsive
as the SF36 in patients with LLI and could, therefore,
potentially replace the SF36 in this patient group.
METHODS
Consecutive patients presenting to the Academic Vas-
cular Surgical Unit at Hull Royal Infirmary between August
and December 2006 with varying degrees of LLI were
invited to participate in the study. In total, 193 patients
were studied (135men, 58 women), median age 66 (range,
44-84) years. Patients with intermittent claudication com-
pleted a treadmill test (speed 2.5 km/hour; gradient 10°).
Pre and post treadmill ankle brachial pressure indices
(ABPI) were recorded and the patient’s disease severity
graded according to the International Society of Cardiovas-
cular Surgery (ISCVS) suggested reporting standard (30
mild, 52 moderate, 73 severe claudicants, 16 rest pain, and
21 tissue loss – Table I).17 All patients completed both the
SF36 and SF8 at the time of the assessment and the time
taken to complete each questionnaire was noted. The num-
ber of questionnaires either incompletely or erroneously
answered was noted and the patient was then assisted to
complete the questionnaire fully.
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assessment of generic health domains that are not specific
to age, disease, or treatment group.13 It contains 36 items
covering eight health-related QoL domains: bodily pain
(BP), physical functioning (PF), role limitations due to
physical problems (RP), role limitations due to emotional
problems (RE), vitality (V), social function (SF), mental
health (MH), and general health (GH). For each domain,
questions are scored, coded, summed, and transformed on
a scale from 0 (worst health) to 100 (best health). In this
study, the United Kingdom version, two of the SF36s were
used. The SF36 has shown acceptable validity and reliability
in population studies and in patients with LLI.15,16
Short Form 8. The SF8 was constructed to replace
the SF36 in population health surveys. It has been trans-
lated and linguistically validated for use in more than 30
languages. The SF8 is an eight-item version of the SF36
that yields a comparable eight-dimension health profile.
Each SF8 single-item scale can be scored on the same
norm-based metrics as the SF36 scales. The SF8 has dem-
onstrated acceptable validity and reliability in population
studies.12
DEFINITIONS
Validity. Validity is defined as “the extent to which an
instrument measures what it purports to measure”.16 Con-
vergent validity assesses the correlation between like do-
mains, while divergent validity assesses the correlation be-
tween non-like domains of the SF36 and SF8 QoL
instruments. Spearman’s rank correlation has been used to
assess correlation between domains. Using the analysis
method outlined above, the demonstration of validity re-
quires the correlation between “like” domains measured by
the different instruments to be greater than the correlation
between non-like domains, ie, the correlation between
SF8-measured pain and SF36-measured pain should be
greater than the correlation between SF8-measured pain
and the other SF36-measured domains.
Reliability. Reliability is defined as the “extent to
which an instrument yields the same results on the same
population under different conditions”.16 Test/retest reli-
ability is reflected in the correlation between scores at two
time periods. Fifty-eight patients (44 men) completed two
sets of questionnaires. The first set was completed at the
time of the initial assessment and the second set completed
Table I. Patient demographics and clinical indicators of L
Claudication
Mild Moderate
n 30 52
Median age (IQR)/years 64 (56-73.5) 67.5 (64-71)
Male:female ratio 23:7 39:13
Median ABPI (IQR) 0.95 (0.83-1.0) 0.93 (0.69-1.0)
IQR, Inter quartile range; ABPI, ankle brachial pressure index; n, numbe
analysis of variance (ANOVA).2 weeks later and returned by post. No interventions wereundertaken between these two time points. Forty-two pa-
tients with claudication and 35 patients with critical limb
ischemia were sent repeat questionnaires. All the claudi-
cants and 16 critical limb ischemic patients returned com-
pleted forms.
Responsiveness. Responsiveness is the ability to de-
tect small but clinically significant changes.16 Responsive-
ness was determined by observing changes in the domain
scores of both QoL questionnaires as lower limb ischemia
became more severe.
Statistical analysis. Data analysis was performed us-
ing SPSS v.13.0.0 for Windows (SPSS Inc, Chicago, Ill).
Convergent/divergent validity and test/retest reliability of
the QoL instruments was analyzed using the Spearman’s
rank correlation test. Kruskall-Wallis analysis of variance
(ANOVA) was used to analyze changes in individual QoL
domains across the whole group, while the Mann-Whitney
U test was used to analyze responsiveness between the
groups of patients with varying severity of LLI. A P value
of  .05 was taken to represent statistical significance.
RESULTS
Increasing LLI is associated with a reduction in the
male to female ratio of patients affected, a significant in-
crease in patients’ age and a significant fall in ABPI (Table
I). Increasing LLI resulted in a significant deterioration in
all eight domains of both the SF8 and the SF36 (P  .05,
Kruskall-Wallis ANOVA – Fig 1). The time taken to com-
plete the SF8 (median 2.5 minutes, range, 1.5-3.5 min-
utes) was significantly shorter than the time taken to com-
plete the SF36 (median 11 minutes, range, 8-20 minutes;
P  .001 Wilcoxon Rank test). Twenty-seven percent of
patients required assistance to complete the SF36 question-
naire as they found some questions confusing, whereas
none of the patients required assistance in completing the
SF8 questionnaire (P  .001 2 test).
Validity (Table II). Convergent validity was greater
than divergent validity for six SF36 domains (PF, RP, GH,
V, SF, MH) and for seven SF8 domains (PF, RP, BP, GH,
V, SF, MH).
Reliability (Table III). Test/retest reliability was ex-
cellent for both the SF36 (0.76 rs 0.86) and the SF8
(0.8 rs 0.88) with the SF8 in general showing higher
correlation coefficients.
Responsiveness (Fig 1, Table IV). For the SF36,
Severe Rest pain Tissue loss P value
73 16 21
5 (60-74) 70 (66-73) 75.5 (69.5-79) .001
51:22 10:6 12:10 .001
5 (0.49-0.8) 0.38 (0.23-0.46) 0.22 (0.18-0.42) .001
, lower limb ischemia. Statistical analysis undertaken using Kruskall-WallisLI
6
0.6
r; LLIsignificant differences were seen between mild claudicants
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difference between moderate and severe claudicants was
seen for any domain. No significant difference was seen
between moderate claudicants and those patients with crit-
ical limb ischemia for the domains of GH and V, although
there were significant differences seen between severe clau-
dicants and patients with critical limb ischemia for these
two domains. No differences were seen in domain scores
when comparing patients with rest pain and patients with
tissue loss.
For the SF8, mild claudicants had significant differ-
ences with all the other groups of patients except for the
domain of social function. No significant differences were
seen between moderate and severe claudicants for any
domains. In the SF8 domains of GH, V, and MH, no
significant differences were seen between patients with
moderate/severe claudicants and those with critical limb
ischemia. Furthermore, no differences were seen in domain
scores when comparing patients with rest pain and patients
with tissue loss. In summary, the SF8 is as responsive as the
SF36 in three of the eight QoL domains (PF, RP, and BP)
and more responsive in one QoL domain (RE) but less
responsive in four QoL domains (GH, V, MH, and SF).
DISCUSSION
QoL analysis is now an integral outcome measure in
Fig 1. a, Variation in the SF36 quality of life domains with
increasing lower limb ischaemia. b, Variation in theSF8 quality of
life domains with increasing lower limb ischaemia.LLI.6,9 Initial studies concentrated predominantly upongeneric QoL tools with most using the SF36 as their
preferred instrument.3,16 The SF36 is without doubt the
most widely used generic QoL instrument worldwide al-
lowing comparison between different disease states and
populations. The SF36 has also been recommended as the
“gold standard” generic QoL instrument in the assessment
of patients with LLI.16 However, critics of the SF36 claim
it is prolonged, takes excessive time to complete, and
generates an unacceptably high incidence of incomplete
data sets.18 The ideal QoL instrument, in addition to being
valid and reliable, should be sufficiently brief to achieve
high response and completion rates, although sufficiently
detailed to ensure adequate responsiveness. It should be
simple for patients to comprehend and complete, and for
health professionals to administer, score, and analyze. On
this basis, the SF8 has been developed as a more concise
version of the SF36 allowing both brevity and comprehen-
siveness in population health surveys.12 By having only
eight items, the SF8, therefore, relies on a single item to
measure each of the eight domains in the SF-36. The recent
development of the SF8 means that the instrument cur-
rently lacks the depth of validation data that is available for
the SF36, data that is necessary before it can be recom-
mended for routine practice.
Our results show that convergent/divergent validity is
good for both the instruments but seems stronger (“like-
domains” correlation coefficient greater than “unlike”) for
the SF8 (seven of eight domains) than the SF36 (six of the
eight domains). Reliability is strong for both QoL instru-
ments but the correlation coefficients were on the whole
higher for the SF8 than the SF36. The SF8 is a much
shorter questionnaire, and as such, there may be an element
of patient recall rather than reliability per se. However,
previous work has shown that in a similar cohort of patients,
the use of three differing lengths of QoL questionnaires
resulted in similar test/retest reliability results suggesting
that the results we observed were likely a true reflection of
reliability.16
This study also confirmed previous findings that in-
creasing LLI has a progressively detrimental impact on
patient reported QoL, but this is the first study to demon-
strate these findings using the SF8.16 No difference was
observed in any of the SF36 or the SF8 domain scores
between moderate and severe claudicants or patients with
rest pain and tissue loss. This would suggest that when
treating claudicants, an improvement to, at minimum, mild
claudication is required and patients with critical limb ische-
mia need not only tissue healing but also absolution of rest
pain to register QoL improvement. In comparison to the
SF36, the SF8 demonstrated slightly inferior responsive-
ness in four domains, namely GH, SF, V, and MH. How-
ever, as these domains are frequently unaffected by small
shifts in LLI severity, the importance of this finding is
contentious and may be compensated for by the SF8’s
simplicity, brevity, patient acceptability, and completion
rates. Of specific interest is the difference between domain
scores in moderate claudicants and those patients with
critical limb ischemia. The only difference between the two
e loss.
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However, an alternative health domain to measure psycho-
logical status is the RE domain that does show a significant
difference between these two groups of patients.
The importance of QoL analysis in LLI is also evident
Table II. Convergent (bold) and divergent validity: cor
the SF8
SF8 domains PF BP RP
PF 0.71 0.69 0.63
BP 0.67 0.67 0.66
RP 0.59 0.60 0.75
GH 0.51 0.60 0.50
V 0.55 0.66 0.55
SF 0.61 0.65 0.57
RE 0.51 0.59 0.57
MH 0.52 0.57 0.52
PF, Physical functioning; BP, bodily pain; RP, physical problems; GH, gen
health; SF8, short form 8; SF36, short form 36.
Table III. Test/retest reliability coefficients (rs) for the SF
SF36 domains rs P
Physical functioning 0.84 .0001
Role physical 0.78 .0001
Bodily pain 0.8 .0001
General health 0.86 .0001
Vitality 0.84 .0001
Social functioning 0.78 .0001
Role emotional 0.76 .0001
Mental health 0.84 .0001
(rs) – Spearman’s rank correlation coefficient.
Table IV. Responsiveness analysis for SF36 and SF8 instr
1v2 1v3 1v4 1v5
SF36 Domains
Physical Functioning X X X X
Role Physical X X X X
Bodily Pain X X X X
General Health X NS X X
Vitality X X X X
Social Functioning X X X X
Role Emotional NS X X X
Mental Health X X X X
SF8 Domains
Physical Functioning X X X X
Role Physical X X X X
Bodily Pain X X X X
General Health X X X X
Vitality X X X X
Social Functioning NS NS X X
Role Emotional X X X X
Mental Health X X X X
LLI, Lower limb ischemia; X: P  .05, (Mann-Whitney U test). NS, not sig
classification: 1  mild, 2  moderate, 3  severe, 4  rest pain, 5  tissuby the number of disease-specific QoL tools that have beendeveloped over the last decade and, on the whole, disease-
specific QoL instruments may be more responsive than ge-
neric QoL instruments as well as having greater validity.11,19
It has been suggested that the King’s College Hospital’s
Vascular Quality of Life Questionnaire (VASCU-QoL) is the
ion coefficients for domains measured by the SF36 and
SF36
H V SF RE MH
.55 0.56 0.66 0.50 0.43
.57 0.57 0.67 0.54 0.44
.52 0.55 0.55 0.42 0.49
.70 0.69 0.63 0.48 0.53
.65 0.78 0.61 0.52 0.56
.58 0.65 0.79 0.62 0.59
.60 0.60 0.63 0.59 0.62
.57 0.62 0.61 0.57 0.73
alth; V, vitality; SF, social function; RE, emotional problems; MH, mental
nd the SF8
SF8 domains rs P
Physical functioning 0.88 .0001
Role physical 0.82 .0001
Bodily pain 0.84 .0001
General health 0.8 .0001
Vitality 0.82 .0001
Social functioning 0.8 .0001
Role emotional 0.82 .0001
Mental health 0.88 .0001
ts for LLI
v3 2v4 2v5 3v4 3v5 4v5 Total
S X X X X NS 8/10
S X X X X NS 8/10
S X X X X NS 8/10
S NS NS X X NS 5/10
S NS NS X X NS 6/10
S X X X X NS 8/10
S X X NS NS NS 5/10
S X X X X NS 8/10
S X X X X NS 8/10
S X X X X NS 8/10
S X X X X NS 8/10
S NS NS NS NS NS 4/10
S NS NS NS NS NS 4/10
S X X X X NS 6/10
S X X X X NS 8/10
S NS NS X NS NS 5/10
nt, Total: number of significant differences between groups. ISCVS diseaserelat
G
0
0
0
0
0
0
0
0
eral he36 aumen
2
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
nificaonly disease-specific QoL instrument that merits routine use
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tial in LLI, to enable comparisons between differing chronic
disease states and as a basis for economic evaluation of inter-
vention. We ourselves have not analyzed the effect of inter-
vention in this cohort of patients. Previous work undertaken
using the SF36 has shown that this tool is responsive to the
effects of successful intervention in patients with LLI.20,21
Interventional claudication studies are ongoing using the SF8,
but given the data presented in this paper, the SF8 may be
expected to be as responsive as the SF36 in this regard.
Our results show that the SF8 is, on the whole, as valid,
reliable, and responsive as the SF36, but importantly takes
less time to complete, appears to be less confusing, and is,
therefore, likely to be more acceptable to the patient across
the disease spectrum of LLI. We therefore suggest that SF8
may challenge the SF36 as the gold standard generic QoL
analysis instrument in LLI.
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